What is the etiopathogenesis of septic shock?

Etiopathogenesis of Septic Shock

Septic shock arises from a dysregulated host immune response to infection that triggers simultaneous hyperinflammation and immunosuppression, leading to profound endothelial dysfunction, microcirculatory collapse, cellular metabolic failure, and ultimately multi-organ dysfunction. 1

Initial Pathogen Recognition and Inflammatory Cascade

The pathogenic sequence begins when pattern-recognition receptors on immune cells detect pathogen-associated molecular patterns (PAMPs) from invading microorganisms—predominantly Gram-negative and Gram-positive bacteria occurring with approximately equal frequency, though fungi (particularly Candida) account for a significant minority of cases. 1, 2

• This recognition activates inflammatory signaling pathways that converge toward nuclear factor-κB (NF-κB) and interferon regulatory factor (IRF) signaling, driving production of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6, and IL-8. 1
• Damage-associated molecular patterns (DAMPs) released from injured host tissues further amplify this inflammatory cascade, creating a self-perpetuating cycle. 1
• The massive cytokine release impairs myocardial contractility, reduces vascular responsiveness to catecholamines, and drives systemic inflammation. 1

Endothelial Dysfunction and Coagulopathy

A critical pathogenic mechanism involves transformation of the endothelium from its physiologic anticoagulant state to a procoagulant phenotype. 1

• Endothelial glycocalyx degradation increases vascular permeability, allowing plasma fluid and proteins to leak into interstitial spaces and exacerbating tissue edema. 1
• The coagulation system activates primarily through upregulation of tissue factor (TF), leading to excessive fibrin deposition and reduced plasmin activity. 1
• This creates a vicious cycle where inflammation induces and exacerbates coagulopathies and endothelial injury. 1
• Disrupted endothelium leads to loss of intravascular fluid, recruitment of inflammatory cells, and activation of the coagulation cascade. 1

Hemodynamic and Microcirculatory Collapse

The hallmark circulatory dysfunction manifests as profound vasodilation combined with increased vascular permeability. 1

• Fluid leakage into tissues contributes to hypovolemia despite potentially adequate intravascular volume replacement. 1
• Microcirculatory dysfunction results in tissue hypoperfusion even when macrocirculatory parameters (blood pressure, cardiac output) appear normal—a critical pitfall in management. 1
• Clinically, this manifests as hypotension requiring vasopressors to maintain mean arterial pressure ≥65 mmHg. 1, 3

Cellular Metabolic Failure

Profound metabolic derangements occur at the cellular level, driving organ dysfunction. 1

• Inflammatory cytokines and stress hormones trigger a catabolic state that upregulates hormone-sensitive lipase, causing massive lipolysis with free fatty acid (FFA) levels rising up to four-fold. 1
• Simultaneously, fatty-acid oxidation enzymes are downregulated and ketone production is suppressed, preventing tissues from utilizing mobilized lipids. 1
• Accumulation of toxic FFAs damages organ structures and impairs mitochondrial function, worsening cellular energy deprivation. 1
• Severe lactic acidosis develops as altered cellular metabolism leads to lactate accumulation (>2 mmol/L in septic shock), which further impairs cellular enzyme activity and myocardial contractility. 1, 3
• Sepsis-induced hyperglycemia shunts excess glucose to immune cells for aerobic glycolysis, paradoxically amplifying pro-inflammatory cytokine release and promoting myocardial apoptosis. 1

Biphasic Immune Response

Contemporary understanding recognizes sepsis as a simultaneous coexistence of hyperinflammation and immunosuppression rather than strictly sequential phases. 1

Early Hyperinflammatory Phase

• A subset of patients experiences a dominant early inflammatory response precipitating rapid multi-organ failure and death. 1

Immunosuppressive Phase

• Extensive apoptosis of lymphocytes, B cells, and dendritic cells leads to profound depletion of immune effector cells, with persistent lymphopenia serving as an independent predictor of mortality. 1
• Surviving neutrophils display impaired phagocytic capacity and abnormal calcium signaling despite normal appearance, reducing bacterial clearance. 1
• Monocytes exhibit markedly reduced HLA-DR expression, signifying immune paralysis and compromised antigen presentation. 1
• Bone marrow mobilizes immature polymorphonuclear leukocytes and myeloid-derived suppressor cells (MDSCs), contributing to immunosuppression. 1
• Monocyte differentiation skews toward an M2 macrophage phenotype secreting anti-inflammatory cytokines (IL-10, TGF-β). 1
• Professional antigen-presenting cells downregulate HLA-DR while T cells upregulate inhibitory co-stimulatory molecules (PD-1, PD-L1), expanding regulatory and anergic T-cell populations. 1

Chronic Critical Illness Trajectory

Survivors of the early phase may develop Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS), characterized by ongoing inflammation, immune dysfunction, muscle wasting, reactivation of latent viral infections, and heightened susceptibility to nosocomial pathogens. 1

• Systemic catabolism of glycogen, fat, and protein releases substrates diverted from maintaining peripheral muscle mass toward immune-mediated repair processes. 1
• Resultant skeletal muscle tissue loss imposes both short-term and long-term functional deficits for survivors. 1

Critical Pitfalls in Understanding Pathophysiology

• Microcirculatory dysfunction can persist despite normalized blood pressure with vasopressors—clinicians must recognize that adequate MAP does not guarantee tissue perfusion. 1
• Lactate elevation reflects cellular metabolic dysfunction, not merely tissue hypoxia, making it an essential marker even in patients with restored blood pressure. 1
• Prolonged shock beyond critical time thresholds leads to irreversible cellular injury—once cells reach this point, restoration of perfusion cannot prevent cell death, underscoring the necessity for early aggressive intervention. 1
• Most patients with prolonged sepsis acquire opportunistic infections, reflecting the progression to an immunosuppressive disorder that is often underrecognized. 1